Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mydecine Innovations Group Inc
(OP:
MYCOF
)
0.0044
UNCHANGED
Streaming Delayed Price
Updated: 1:04 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mydecine Innovations Group Inc
< Previous
1
2
3
4
5
6
7
Next >
Which Psychedelic Stock ETF Is Right For You?
September 18, 2021
This week the AdvisorShares Psychedelics ETF began trading on the NYSE Arca. Here we compare the make-up of the now 3 psychedelic stock ETFs and two tracking indexes.
Via
Talk Markets
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
September 13, 2021
Last Week In Psychedelics:
Via
Benzinga
Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week
September 11, 2021
The performance of the psychedelic-focused index components substantially outshone the weed stocks.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
National Suicide Prevention Week Shines Light on Psychedelic Treatments
September 09, 2021
Via
FinancialNewsMedia
Psychedelic Drug Industry Report Card For 2021
September 01, 2021
In assessing the psychedelic drug industry, a primary focus for investors is drug development.
Via
Talk Markets
Magic Mushroom Drug Stock Performances YTD
August 29, 2021
Of the 35 companies involved in clinical stage research of psychedelic substances, 20 are researching the benefits of psilocybin, the primary psychoactive ingredient in “magic mushrooms”.
Via
Talk Markets
PharmaDrug Strikes Deal With Johns Hopkins University For A Clinical Trial Into Psychedelic DMT
August 26, 2021
On Wednesday, PharmaDrug Inc. (CSE:PHRX) (OTC:
Via
Benzinga
Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up
August 23, 2021
Beckley Psytech Closes $80 Million Series B Beckley Psytech announced
Via
Benzinga
Mydecine Innovations Inks Deal With Johns Hopkins University To Undertake Psychedelics Research Into Smoking Cessation
August 18, 2021
Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) has signe...
Via
Benzinga
Which Psychedelic Drug Stock Category Outperformed Last Week
August 10, 2021
Which has performed best YTD, the Pure-Play Marijuana Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Which Psychedelic Drug Has The Most Commercial Potential?
August 10, 2021
As the Mental Health Crisis has become a mental health pandemic, clinical research on psychedelic drugs is showing that these substances are the best – and only – option to address this crisis.
Via
Talk Markets
Marijuana Vs. Mushroom Psychedelic Drug Stocks: A Current & YTD Performance Comparison
July 24, 2021
We identify the performance of the top 8 clinical-stage psychedelic companies in each of the marijuana and mushroom drug stock categories during the past 5 trading days, July to date, and YTD.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
July 21, 2021
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
Telehealth Boom Is Driving this Mental Health Company’s Progress
July 13, 2021
Via
FinancialNewsMedia
How The Pot And Psychedelic Stocks Performed Last Week And YTD
July 13, 2021
Approximately 100 clinical-stage marijuana and mushroom/ketamine psychedelic drug stocks now trade on the various North American stock exchanges.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
How To Invest In "Magic Mushrooms" (Psychedelics)
July 09, 2021
A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest.
Via
Talk Markets
Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies
July 07, 2021
This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Ps...
Via
Benzinga
The 6 Leading Psychedelic Stocks In Drug R&D
July 07, 2021
Drug R&D in the emerging psychedelic drug industry continues to advance. Share prices continue to lag. Here's a comparison of the strengths and weaknesses of six of the leaders in psychedelic drug R&D...
Via
Talk Markets
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies
July 02, 2021
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o...
Via
Benzinga
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More
June 30, 2021
Institutional analysts are taking a liking to the industry ...
Via
Benzinga
Psyched: Atai Life Sciences Hits Nasdaq, Canada To Fund Ketamine Trials, Mydecine Launches AI Drug-Discovery Platform
June 21, 2021
Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Mydecine Identifies 4 Psychedelic-Related Drugs to Tackle the Mental Health Crisis
June 17, 2021
Photo by Christopher Ott on
Via
Benzinga
Mydecine Innovations Group Launches AI-Assisted Drug Discovery Program
June 16, 2021
Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF), a biotech company in the ...
Via
Benzinga
Psychedelic Drug Stocks Index -21% In May; Now -25% YTD
May 31, 2021
46 psychedelic drug stocks now trade on the various North American stock exchanges and the 11 with the largest market capitalizations make up the Pure-Play Psychedelic Drug Stocks Index.
Via
Talk Markets
Psyched: Nasdaq Gets Its Third Psychedelics Company, Mynd Goes Public, Delic Buys New Research Facility
May 28, 2021
The Nasdaq welcomed its third psychedelics company this week, with
Via
Benzinga
Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update
May 20, 2021
Via
Get News
Mydecine To Spin-Out Its U.S. Cannabis Assets By Mid July
May 19, 2021
Psychedelics and mycology company, Mydecine Innovations Group Inc. (NEO: MYCO) (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Next Psychedelic Stock To Uplist On The Nasdaq?
May 04, 2021
As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next?
Via
Talk Markets
Mydecine Posts $26.9M Net Loss For 2020: What's Ahead For Psychedelic Stock
May 04, 2021
Denver-based Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF
Via
Benzinga
Second-Chance Buying Opportunity With Psychedelic Stock Warrants
April 27, 2021
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.